The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.
 
Matthew Joseph Wieduwilt
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Gilead Sciences; SERVIER
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; Gilead Sciences; Pfizer; SERVIER
Research Funding - NCI (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
Other Relationship - Sorrento Therapeutics
 
Jun Yin
Employment - Mayo Clinic
 
Oudom Kour
No Relationships to Disclose
 
Rebecca Teske
No Relationships to Disclose
 
Wendy Stock
Honoraria - Abbvie; Pfizer
Consulting or Advisory Role - AstraZeneca; BEAm; Deciphera; GlaxoSmithKline; Jazz Pharmaceuticals; Kite, a Gilead company; Kronos Bio; Kura Oncology; morphosys; Newave Pharmaceutical; Pfizer; Pluristem Therapeutics; SERVIER
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer
 
Kenneth Byrd
No Relationships to Disclose
 
Kimberley Doucette
Consulting or Advisory Role - Cellectar
 
James K. Mangan
No Relationships to Disclose
 
Gregory A. Masters
No Relationships to Disclose
 
Alice S. Mims
No Relationships to Disclose
 
Katarzyna Jamieson
No Relationships to Disclose
 
Shira Naomi Dinner
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Pfizer
 
Ali W. Bseiso
No Relationships to Disclose
 
Geoffrey Lim Uy
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis
 
Harry Paul Erba
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Bristol-Myers Squibb/Celgene; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Janssen Oncology; Jazz Pharmaceuticals; Kura Oncology; Macrogenics; Novartis; Pfizer; Sumitomo Dainippon Pharma Oncology; Takeda; Trillium Therapeutics
Speakers' Bureau - Abbvie; Agios; Bristol Myers Squibb Foundation; Incyte; Jazz Pharmaceuticals; Novartis; SERVIER
Research Funding - Abbvie (Inst); Abbvie (Inst); Agios (Inst); ALX Oncology (Inst); Amgen (Inst); Aptose Biosciences (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Gilead/Forty Seven (Inst); Glycomimetics (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Macrogenics (Inst); Novartis (Inst); PTC Therapeutics (Inst); SERVIER; Sumitomo Dainippon Pharma Oncology (Inst)
Other Relationship - Bristol-Myers Squibb/Celgene; Celgene; Glycomimetics
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo
 
Mark Robert Litzow
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Abbvie; Actinium Pharmaceuticals; Amgen; Astellas Pharma; Novartis; Pluristem Therapeutics; Syndax
Other Relationship - Biosight
 
Richard M. Stone
Honoraria - DAVA Pharmaceuticals; Medscape; Prime Oncology; Research to Practice
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Amgen; Aprea Therapeutics; Aptevo Therapeutics; Arog; AvenCell; BerGenBio; Boston Pharmaceuticals; Bristol Myers Squibb; CTI BioPharma Corp; ElevateBio; Epizyme; Foghorn Therapeutics; Gemoab; GlaxoSmithKline; Innate Pharma; Janssen; Jazz Pharmaceuticals; Kura Oncology; Novartis; Onconova Therapeutics; Rigel; Syndax; Syntrix Biosystems; Syros Pharmaceuticals; Takeda
Research Funding - Abbvie/Genentech (Inst); Agios (Inst); Novartis (Inst)